| 1 |
Yin M, Tong J, Meng F, Liu C, Liu X, Fang F, He Z, Qin X, Liu C, Ni D, Gao Y, Liang H, Zhang X, Luo L. Near-Infrared-II Activatable Symbiotic 2D Carbon–Clay Nanohybrids for Dual Imaging-Guided Combinational Cancer Therapy. ACS Appl Mater Interfaces 2022. [DOI: 10.1021/acsami.2c11340] [Reference Citation Analysis]
|
| 2 |
Clausen AS, Christensen C, Christensen E, Cold S, Kristensen LK, Hansen AE, Kjaer A. Development of a 64Cu-labeled CD4+ T cell targeting PET tracer: evaluation of CD4 specificity and its potential use in collagen-induced arthritis. EJNMMI Res 2022;12. [DOI: 10.1186/s13550-022-00934-7] [Reference Citation Analysis]
|
| 3 |
Zhou L, Wu J, Sun Z, Wang W. Oxidation and Reduction Dual-Responsive Polymeric Prodrug Micelles Co-delivery Precisely Prescribed Paclitaxel and Honokiol for Laryngeal Carcinoma Combination Therapy. Front Pharmacol 2022;13:934632. [DOI: 10.3389/fphar.2022.934632] [Reference Citation Analysis]
|
| 4 |
Wang Z, Li J, Lin G, He Z, Wang Y. Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics. J Control Release 2022;348:1066-88. [PMID: 35718211 DOI: 10.1016/j.jconrel.2022.06.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 5 |
Chen X, Niu W, Du Z, Zhang Y, Su D, Gao X. 64Cu radiolabeled nanomaterials for positron emission tomography (PET) imaging. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.02.070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Su T, Feng X, Yang J, Xu W, Liu T, Zhang M, Ding J, Chen X. Polymer nanotherapeutics to correct autoimmunity. J Control Release 2022:S0168-3659(21)00689-1. [PMID: 34990701 DOI: 10.1016/j.jconrel.2021.12.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 7 |
Shi D, Beasock D, Fessler A, Szebeni J, Ljubimova JY, Afonin KA, Dobrovolskaia MA. To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives. Adv Drug Deliv Rev 2022;180:114079. [PMID: 34902516 DOI: 10.1016/j.addr.2021.114079] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 40.0] [Reference Citation Analysis]
|
| 8 |
Li M, Li Y, Li S, Jia L, Du C, Li M, Li S, Galons H, Guo N, Yu P. Co-delivery of F7 and crizotinib by thermosensitive liposome for breast cancer treatment. J Liposome Res 2021;:1-11. [PMID: 34904521 DOI: 10.1080/08982104.2021.2001499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Zhao Y, Liu Y, Wang Y, Xu B, Zhang S, Liu J, Zhang T, Jin L, Song S, Zhang H. Rapidly clearable MnCo2O4@PAA as novel nanotheranostic agents for T1/T2 bimodal MRI imaging-guided photothermal therapy. Nanoscale 2021;13:16251-7. [PMID: 34549746 DOI: 10.1039/d1nr04067g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Jæhger DE, Hübbe ML, Kræmer MK, Clergeaud G, Olsen AV, Stavnsbjerg C, Wiinholt MN, Kjær A, Henriksen JR, Hansen AE, Andresen TL. Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigens. Sci Rep 2021;11:19794. [PMID: 34611284 DOI: 10.1038/s41598-021-99347-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 11 |
Zhang Y, Xia Q, Wu T, He Z, Li Y, Li Z, Hou X, He Y, Ruan S, Wang Z, Sun J, Feng N. A novel multi-functionalized multicellular nanodelivery system for non-small cell lung cancer photochemotherapy. J Nanobiotechnology 2021;19:245. [PMID: 34391438 DOI: 10.1186/s12951-021-00977-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 12 |
Kostrikov S, Johnsen KB, Braunstein TH, Gudbergsson JM, Fliedner FP, Obara EAA, Hamerlik P, Hansen AE, Kjaer A, Hempel C, Andresen TL. Optical tissue clearing and machine learning can precisely characterize extravasation and blood vessel architecture in brain tumors. Commun Biol 2021;4:815. [PMID: 34211069 DOI: 10.1038/s42003-021-02275-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Jiang X, Pan D, Tao M, Zhang T, Zeng X, Wu Z, Guo Y. New Nanocarrier System for Liposomes Coated with Lactobacillus acidophilus S-Layer Protein to Improve Leu-Gln-Pro-Glu Absorption through the Intestinal Epithelium. J Agric Food Chem 2021;69:7593-602. [PMID: 34190554 DOI: 10.1021/acs.jafc.1c01498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Meng W, He C, Hao Y, Wang L, Li L, Zhu G. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Drug Deliv 2020;27:585-98. [PMID: 32264719 DOI: 10.1080/10717544.2020.1748758] [Cited by in Crossref: 118] [Cited by in F6Publishing: 96] [Article Influence: 59.0] [Reference Citation Analysis]
|
| 15 |
Zhang Z, Chu Y, Li C, Tang W, Qian J, Wei X, Lu W, Ying T, Zhan C. Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines. Journal of Controlled Release 2021;330:493-501. [DOI: 10.1016/j.jconrel.2020.12.047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 16 |
Pellico J, Gawne PJ, T M de Rosales R. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev 2021;50:3355-423. [PMID: 33491714 DOI: 10.1039/d0cs00384k] [Cited by in Crossref: 50] [Cited by in F6Publishing: 60] [Article Influence: 25.0] [Reference Citation Analysis]
|
| 17 |
Aronson MR, Medina SH, Mitchell MJ. Peptide functionalized liposomes for receptor targeted cancer therapy. APL Bioeng 2021;5:011501. [PMID: 33532673 DOI: 10.1063/5.0029860] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 18 |
Falanga A, Del Genio V, Galdiero S. Peptides and Dendrimers: How to Combat Viral and Bacterial Infections. Pharmaceutics 2021;13:101. [PMID: 33466852 DOI: 10.3390/pharmaceutics13010101] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 19 |
Børresen B, Hansen AE, Fliedner FP, Henriksen JR, Elema DR, Brandt-Larsen M, Kristensen LK, Kristensen AT, Andresen TL, Kjær A. Noninvasive Molecular Imaging of the Enhanced Permeability and Retention Effect by 64Cu-Liposomes: In vivo Correlations with 68Ga-RGD, Fluid Pressure, Diffusivity and 18F-FDG. Int J Nanomedicine 2020;15:8571-81. [PMID: 33173294 DOI: 10.2147/IJN.S239172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 20 |
Clausen AS, Østergaard DE, Holmberg P, Henriksen JR, Tham J, Damborg PP, Jensen AI, Kjaer A, Hansen AE, Andresen TL. Quantitative determination of 64Cu-liposome accumulation at inflammatory and infectious sites: Potential for future theranostic system. J Control Release 2020;327:737-46. [PMID: 32920081 DOI: 10.1016/j.jconrel.2020.09.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 21 |
Zhao Y, Cai F, Shen X, Su H. A high stable pH-temperature dual-sensitive liposome for tuning anticancer drug release. Synth Syst Biotechnol 2020;5:103-10. [PMID: 32596520 DOI: 10.1016/j.synbio.2020.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 22 |
Wu B, Zhang LJ, Zhang CJ, Deng K, Ao YW, Mei H, Zhou W, Wang CX, Yu H, Huang SW. Effect of Poly(ethylene glycol) (PEG) Surface Density on the Fate and Antitumor Efficacy of Redox-Sensitive Hybrid Nanoparticles. ACS Biomater Sci Eng 2020;6:3975-83. [PMID: 33463329 DOI: 10.1021/acsbiomaterials.0c00516] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 23 |
Wang W, Fliedner FP, Hansen AE, Eliasen R, Melander F, Kjaer A, Andresen TL, Jensen AI, Henriksen JR. Preclinical evaluation of cationic DOTA-triarginine-lipid conjugates for theranostic liquid brachytherapy. Nanotheranostics 2020;4:142-55. [PMID: 32483520 DOI: 10.7150/ntno.44562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Šimečková P, Hubatka F, Kotouček J, Turánek Knötigová P, Mašek J, Slavík J, Kováč O, Neča J, Kulich P, Hrebík D, Stráská J, Pěnčíková K, Procházková J, Diviš P, Macaulay S, Mikulík R, Raška M, Machala M, Turánek J. Gadolinium labelled nanoliposomes as the platform for MRI theranostics: in vitro safety study in liver cells and macrophages. Sci Rep 2020;10:4780. [PMID: 32179785 DOI: 10.1038/s41598-020-60284-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 25 |
Zhang Z, Zhang Y, Song S, Yin L, Sun D, Gu J. Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals. J Sep Sci 2020;43:1978-97. [DOI: 10.1002/jssc.201901340] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 26 |
d'Avanzo N, Celia C, Barone A, Carafa M, Di Marzio L, Santos HA, Fresta M. Immunogenicity of Polyethylene Glycol Based Nanomedicines: Mechanisms, Clinical Implications and Systematic Approach. Adv Therap 2020;3:1900170. [DOI: 10.1002/adtp.201900170] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 27 |
Zhu J, Zhang H, Chen K, Li Y, Yang Z, Chen S, Zheng X, Zhou X, Jiang ZX. Peptidic Monodisperse PEG "Comb" as Multifunctional "Add-On" Module for Imaging-Traceable and Thermo-Responsive Theranostics. Adv Healthc Mater 2020;9:e1901331. [PMID: 31851435 DOI: 10.1002/adhm.201901331] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 28 |
Hong L, Wang Z, Wei X, Shi J, Li C. Antibodies against polyethylene glycol in human blood: A literature review. J Pharmacol Toxicol Methods 2020;102:106678. [PMID: 31981619 DOI: 10.1016/j.vascn.2020.106678] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 29 |
de Maar JS, Sofias AM, Porta Siegel T, Vreeken RJ, Moonen C, Bos C, Deckers R. Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment. Theranostics 2020;10:1884-909. [PMID: 32042343 DOI: 10.7150/thno.38625] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 30 |
Pérez-Medina C, Teunissen AJP, Kluza E, Mulder WJM, van der Meel R. Nuclear imaging approaches facilitating nanomedicine translation. Adv Drug Deliv Rev 2020;154-155:123-41. [PMID: 32721459 DOI: 10.1016/j.addr.2020.07.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 31 |
Pan A, Jakaria MG, Meenach SA, Bothun GD. Radiofrequency and Near-Infrared Responsive Core–Shell Nanostructures Using Layersome Templates for Cancer Treatment. ACS Appl Bio Mater 2020;3:273-81. [DOI: 10.1021/acsabm.9b00797] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Lee W, Im HJ. Theranostics Based on Liposome: Looking Back and Forward. Nucl Med Mol Imaging 2019;53:242-6. [PMID: 31456856 DOI: 10.1007/s13139-019-00603-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 33 |
Gudbergsson JM, Jønsson K, Simonsen JB, Johnsen KB. Systematic review of targeted extracellular vesicles for drug delivery – Considerations on methodological and biological heterogeneity. Journal of Controlled Release 2019;306:108-20. [DOI: 10.1016/j.jconrel.2019.06.006] [Cited by in Crossref: 70] [Cited by in F6Publishing: 61] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 34 |
Bavli Y, Winkler I, Chen BM, Roffler S, Cohen R, Szebeni J, Barenholz Y. Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs. J Control Release 2019;306:138-48. [PMID: 31176656 DOI: 10.1016/j.jconrel.2019.06.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 35 |
Man F, Gawne PJ, T M de Rosales R. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev 2019;143:134-60. [PMID: 31170428 DOI: 10.1016/j.addr.2019.05.012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 36 |
Xia Y, Xu C, Zhang X, Ning P, Wang Z, Tian J, Chen X. Liposome-based probes for molecular imaging: from basic research to the bedside. Nanoscale 2019;11:5822-38. [DOI: 10.1039/c9nr00207c] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
|
